BIO Asia–Taiwan 2021 亞洲生技大會

BIO Asia–Taiwan 2021 亞洲生技大會



Build Solid Growth in Asia (Regist now at Early Bird Rate before June 15)

BIO Asia-Taiwan 2021 Online + Onsite

Asian region persists in developing quality research, cutting-edge technology, and innovative businesses. Moreover, there are diverse exit strategies available, and many developing biotech companies have received favorable valuations in capital and public markets.


Join us at BIO Asia-Taiwan 2021 to explore solid growth and exit strategies for biotech in Asia, with an expert panel discussion on identifying value and building strategic partnerships. Explore our company presentations and entrepreneur pitches, as well as the engagement opportunities with state-of-the-art partnering system!

REGISTER (Early Bird Ends on June 15)
Learn More

Joseph Chou

Chairman and CEO,
PwC Taiwan

Hongbo Lu

Vivo Capital

Michael Brinkman

Managing Director,
Joint US Head of Biopharmaceuticals Investment Banking, Jefferies, LLC

Darren Carroll

Partner, Polaris Partners, previously Chief Business Officer, Eli Lilly

Sinclair Dunlop

Managing Director,
Epidarex Capital

Grace Yeh

Chairman & CEO,
Onward Therapeutics

Lee-Cheng Liu

President & CEO,


Sponsor by